Machine signal
Active cluster sell — 6 distinct insiders, $70.2M, window ends Sep 2, 2026.
Figures computed from official regulatory filings — .
Analysttarget 279.27 USD (+9%) · consensus 4.09/5 · 16 buy · 6 hold · 1 sell
Ownershipinsiders 0.05% · institutions 76.7% · short 1.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for JOHNSON & JOHNSON only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; intraocular lenses for cataract surgery, and other products used in cataract and refractive procedures under the TECNIS brand. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
27 buys631 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| HEWSON MARILLYN A | AwardD (derivative) | $50K | SEC |
| Woods Eugene A. | AwardD (derivative) | $37.5K | SEC |
| Pinto Daniel E | AwardD (derivative) | $31.3K | SEC |
| Schmid Timothy | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schmid Timothy | Exercise | $1.5M | SEC |
| Schmid Timothy | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schmid Timothy | Sell | $3M | SEC |
| Schmid Timothy | Sell | $6.2M | Unusual size | SEC |
| Schmid Timothy | Exercise | $3.4M | Unusual size | SEC |
| Taubert Jennifer L | Sell | $4M | Unusual size | SEC |
| Taubert Jennifer L | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Taubert Jennifer L | Exercise | $1.7M | SEC |
| Duato Joaquin | Sell | $26.7M | Unusual size | SEC |
| Duato Joaquin | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Duato Joaquin | Sell | $5.5M | SEC |
| Duato Joaquin | Exercise | $14.3M | Unusual size | SEC |
| Forminard Elizabeth | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Forminard Elizabeth | Sell | $1.7M | SEC |
| Forminard Elizabeth | Exercise | $1.2M | SEC |
| Duato Joaquin | Sell | $10.8M | SEC |
| Duato Joaquin | Sell | $1.7M | SEC |
| Forminard Elizabeth | Sell | $2.4M | SEC |
| Broadhurst Vanessa | Exercise | $1.4M | SEC |
| Broadhurst Vanessa | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Broadhurst Vanessa | Sell | $5.8M | SEC |